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ABSTRACT
Histone methylation changes and formation of chro-
matin loops involving enhancers, promoters and 3′
end regions of genes have been variously associ-
ated with active transcription in eukaryotes. We have
studied the effect of activation of the retinoic A re-
ceptor, at the RARE–promoter chromatin of CASP9
and CYP26A1 genes, 15 and 45 min following RA ex-
posure, and we found that histone H3 lysines 4 and 9
are demethylated by the lysine-specific demethylase,
LSD1 and by the JMJ-domain containing demethy-
lase, D2A. The action of the oxidase (LSD1) and a
dioxygenase (JMJD2A) in the presence of Fe++ elic-
its an oxidation wave that locally modifies the DNA
and recruits the enzymes involved in base and nu-
cleotide excision repair (BER and NER). These events
are essential for the formation of chromatin loop(s)
that juxtapose the RARE element with the 5′ tran-
scription start site and the 3′ end of the genes. The
RARE bound-receptor governs the 5′ and 3′ end se-
lection and directs the productive transcription cycle
of RNA polymerase. These data mechanistically link
chromatin loops, histone methylation changes and
localized DNA repair with transcription.
INTRODUCTION
Retinoic acid (RA), an active derivative of vitamin A, plays
a role in the regulation of embryonic development, home-
ostasis and differentiation of adult tissues. RA metabolites,
collectively known as retinoids, are well-characterized in-
hibitors of cancer cell proliferation or inducers of stem cell
differentiation. The biological activity of RA is mediated by
its binding to RA receptors (RAR, RAR and RAR )
that function as hetero-dimers with retinoid X receptors
(RXRs), targeting DNA at specific sites, known as RA re-
sponsive elements (RAREs). Following hormone binding,
an active receptor complex induces covalent modifications
at the N-terminal tails of nucleosomal histones and assem-
bles an active transcription complex on chromatin (1).
Despite extensive studies onRA-induced transcription, it
is not known if there is a common set of histone modifica-
tions or how the initiation transcription complex is assem-
bled on regulatory regions. The H3 methylation changes re-
ported so far associated with activation of the receptor(s) by
RA, may be secondary to repression of transcription (2) or
induced by cell differentiation (1,3). Although large DNA
domains and histone modifications have been studied dur-
ing development, the mechanism used by RA to activate
transcription still remains elusive.
To address this issue, we studied two prototypic genes
induced by RA: caspase 9 (CASP9) and Cyp26A1
(CYP26A1). CASP9 contains a functional RARE located
9.5 kb downstream of the transcription start site (TSS) (4),
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whereas the RA-induced CYP26A1 expression is driven by
a compact RARE–promoter (5). We first analyzed the re-
cruitment of RA receptors and RNA polymerase II to the
promoter and RARE sites. Second, we studied the changes
of methylation of lysine 4 (K4) and lysine 9 (K9), following
the recruitment on the chromatin sites of two demethylat-
ing enzymes, LSD1 (KDM1A) and JMJD2A (KDM4A).
It has been reported that LSD1 demethylates H3K4me2
or H3K9me2 and JMJD2A demethylates H3K4-K9 me3
(6). Third, we analyzed the formation after RA exposure of
specific chromatin-DNA domains that connect the 5′ end-
promoter-RARE and the 3′ end site of the RA-target gene.
Our data indicate that histone demethylation, DNA oxida-
tion and chromatin looping induced by RA are temporally
and causally associated with the onset of productive tran-
scription induced by RA, and inhibition of any of these
three events abolishes RA-induced transcription.
MATERIALS AND METHODS
Cells and transfections
Human breast cancer MCF-7 cells were grown at 37◦C in
5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with phenol red, L-glutamine (2 mM), in-
sulin (10g/ml), hydrocortisone (3.75 ng/ml) and 10% fetal
bovine serum (FBS) (Invitrogen). Non-tumorigenic breast
MCF10-2A cells were grown in a 1:1 mixture of DMEM
and Ham’s F12 medium supplemented with 20-ng/ml epi-
dermal growth factor, 100-ng/ml cholera toxin, 0.01-mg/ml
insulin and 500-ng/ml hydrocortisone, 95%; horse serum,
5%. Cells were provided with fresh medium every 3 days.
To evaluate the effect of RA, cells were grown in phenol
red-freemedium containing 10%dextran-charcoal-stripped
FBS for 1–3 days, before being challenged with 300-nMRA
for different times according to the experimental protocol.
To obtain LSD1 knock down with siRNA, cells were
transiently transfected, using a Neon R© Transfection Sys-
tem, with siRNA in medium without serum to a final con-
centration of 10 nM and incubation was continued for 48
h. Scrambled RNA, at the same concentration, was used as
negative control. The same procedure was used to obtain
JMJD2A, OGG1 and APE1 knock down with the specific
siRNAs (see Supplemental Information). To rescue LSD1
activity in knock down experiments with siRNAs, LSD1
full-length cDNA was inserted into the CMV 3xFLAG ex-
pression vector (Sigma-Aldrich). LSD1ALA mutant has
been described elsewhere (7,8). To rescue JMJD2A activity,
cells were transfected with pCMV6-AC-GFP plasmid con-
taining JMJD2A full-length (RG200574, OriGene Tech-
nologies, Inc.). To assess the transfection efficiency at sin-
gle cell level, all transfections were traced with pEGFP Vec-
tor (Clontech) or with BLOCK-iT Alexa Fluor R© Red Fluo-
rescent Control and analyzed by fluorescence-activated cell
sorting (FACS).
RNA extraction and quantitative reverse transcription poly-
merase chain reaction and quantitative polymerase chain re-
action
Total RNA was extracted using TRIzol
(Gibco/Invitrogen). cDNA was synthesized in a 20-l
reaction containing 1 g of total RNA, 100 U of Su-
perscript III Reverse Transcriptase (Invitrogen) and 2 l
random hexamer (20 ng/l) (Invitrogen). mRNA was
reverse-transcribed for 1 h at 50◦C, and the reaction
was heat inactivated for 15 min at 70◦C. The products
were stored at −20◦C. Quantitative reverse transcription
polymerase chain reactions (PCRs) and quantitative PCRs
(qPCRs) were performed on a 7500 Real Time PCR System
(Applied Biosystems) using the SYBR Green-detection
system (FS Universal SYBR Green MasterRox/Roche
Applied Science). The complete list of oligonucleotides
used is reported in Supplementary Table S1.
Chromatin immunoprecipitation
Cells were transfected and/or treated as indicated in the
legends of the figures. The cells (∼2.5 x 106 for each an-
tibody) were fixed for 10 min at room temperature by
adding 1 volume of 2% formaldehyde to a final concen-
tration of 1%; the reaction was quenched by addition of
glycine to a final concentration of 125 mM. Fixed cells were
harvested and the pellet was resuspended in 1 ml of Ly-
sis Buffer (see Supplemental Information) containing 1X
protease inhibitor cocktail (Roche Applied Science). The
lysates were sonicated to have DNA fragments 300–600 bp.
Sonicated samples were centrifuged and supernatants di-
luted 2-fold in the chromatin immunoprecipitation (ChIP)
buffer (Supplemental Information). An aliquot (1/10) of
sheared chromatin was further treated with proteinase K,
extracted with phenol/chloroform and precipitated to de-
termine DNA concentration and shearing efficiency (in-
put DNA). The ChIP reaction was set up according to
the manufacturer’s instructions. Briefly, the sheared chro-
matin was precleared for 2 h with 1 g of non-immune
IgG (Santa Cruz Biotechnology) and 20 l of Protein A/G
PLUS-Agarose (Santa Cruz Biotechnology) saturated with
salmon sperm (1mg/ml). Precleared chromatin was divided
in aliquots and incubated at 4◦C for 16 h with 1 g of
the specific antibody (Supplemental Information) and non-
immune IgG, respectively. The immunocomplexes were re-
covered by incubation for 3 h at 4◦C with 20 l of protein-
A/G agarose, beads were washed with wash buffers accord-
ing to the manufacturer’s instructions and immunoprecip-
itated DNA was recovered and subjected to qPCR using
the primers indicated in the legend of the specific figures,
primers sequences and qPCR protocols are described in
Supplemental Information and in Supplementary Table S1.
8-Oxo-7, 8-dihydro-2′-deoxyguanosine DNA assay
For 8-Oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxo-dG) de-
tection, 106 MCF-7 cells were seeded onto glass slides and
treated with 200 or 500-nMRA for 15–30 min. Control cul-
tures were treated with equivalent vehicle volumes and con-
centrations. After treatments, the cells were fixed 15 min
with 4% paraformaldehyde in phosphate buffered saline
(PBS). The slides were then washed three times with Tris-
buffered saline (TBS)/Tween-20 and permeabilized by se-
rial washes in methanol solutions, prior to be washed with
TBS/Tween-20, blocked for 1 h at 37◦C and incubated
with fluorescein isothiocyanate-labeled protein, that binds
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8-oxo-dG, for 15 h at 4◦C (Biotrin OxyDNA Test, Biotrin,
UK). Cover slips were mounted in Moviol and viewed by
fluorescence. To obtain LSD1 knock down, cells were trans-
fected with specific or control siRNAs. After 48 h, cells were
subjected to different treatments, according to experimen-
tal needs, and processed for fluorescence microscopy. For
single-cell transfection assays, cells were co-transfected with
BLOCK-iTAlexaFluor R©RedFluorescent Control. The ef-
ficiency of transfection was 65%+10. All images were cap-
tured with Axiocammicroscopy (Zeiss) with a 63x objective
in the same conditions of brightness and contrast.
Chromosome conformation capture
The chromosome conformation capture (3C) assay was per-
formed as described (9) with minor adaptations. Briefly, the
NcoI restriction enzymewas used. The cells (2.5× 106) were
crosslinked in 12 ml of PBS with 1% formaldehyde for 10
min at room temperature. The reactionwas quenched by ad-
dition of glycine to a final concentration of 125 mM. Fixed
cells were harvested and the pellet resuspended in 1 ml of
ice-cold lysis buffer (the same used for ChIP experiments).
Nuclei were washedwith 0.5ml of restriction enzyme buffer,
centrifuged and resuspended in 100 l of restriction en-
zyme buffer. Sodium dodecyl sulphate (SDS) was added to
a final concentration of 0.1%, and nuclei were incubated at
37◦C for 15 min. Triton X-100 was added to a final concen-
tration of 1% to sequester SDS. Digestion was performed
with 100 U of restriction enzyme at 37◦C for 16 h. The re-
striction enzyme was inactivated by addition of SDS to 2%
and incubation at 65◦C for 30 min. The reaction was di-
luted into 1-ml ligation reaction buffer (see Supplemental
Methods) and incubated at 16◦C for 18 h with 50 U of T4
DNA Ligase (Roche Applied Science). Ethylenediaminete-
traacetic acid (10 mM) was added to stop the reactions.
Samples were treated with Proteinase K (200 g/ml) and
incubated for 5 h at 55◦C and then overnight at 65◦C to re-
verse the formaldehyde crosslinks. The following day, the
DNA was purified by phenol/chloroform extraction and
ethanol precipitation. Samples were redissolved in 20 l of
Tris-EDTA (TE) buffer. To prepare a control template, we
used a pool of plasmids containing an equimolar amount
of the CASP9 or CYP26A1 inserts spanning the genomic
regions of interest. Five micrograms of plasmid DNA were
digested with NcoI in 50 l of 1x buffer for 8 h at 37◦C and
then ligated in 20 l with 5 U of T4 Ligase at 16◦C for 4 h.
The efficiency of digestion at the end of 3C treatment was
quantified by real-time PCR, amplifying a fragment span-
ning two NcoI (uncut) in different 3C DNA preparations.
Primer sequences and positions and details of PCR and
qPCR protocols are described in Supplemental Informa-
tion and Supplementary Table S1. PCR products were sep-
arated on 1.2% agarose gels, stained with ethidium bromide
and quantified with the imageJ program (RasbandWS, Im-
ageJ, National Institutes of Health, Bethesda, MD, USA;
http: //rsb.info.nih.gov/ij/). The amplified fragments at the
end of the procedure were verified by DNA sequence anal-
ysis.
Statistical analysis
All data are presented as mean ± standard deviation in at
least three experiments in triplicate (n ≥ 9). Statistical sig-
nificance between groups was determined using Student’s
t-test (matched pairs test or unmatched test was used as in-
dicated in figure legends). All tests were performed using the
JMP Statistical DiscoveryTM software by SAS.
RESULTS
Recruitment of RA receptor and activation of RNA poly-
merase II at RA-target promoters
The biological activity of RA is mediated by its binding
to RA receptors (RAR, RAR and RAR ), which func-
tion as hetero-dimers with RXRs, targeting specific sites
(RAREs).We have used breast cancer cellsMCF-7, because
they express RARs and respond to RA (10). We studied in-
duction by RA of CASP9 and CYP2626A1 (Figure 1a and
Supplementary Figure S1a) by exposingMCF-7 cells toRA
and measuring mRNA levels at different times following
stimulation. Figure 1b and Supplementary Figure S1b show
that both mRNAs accumulate 30 min after RA exposure.
After a transient reduction at 60 min (a slight, but repro-
ducible, decrease inCYP26A1mRNA), their levels reached
amaximum 4 h after RA exposure. InCASP9, a RARE ele-
ment is localized in intron II, 9.5 kb downstream of the TSS
(Figure 1a). CYP26A1, instead, contains a RARE contigu-
ous with the promoter (−150 bp from the TSS) and another
site at the 3′ end close to the polyA (Supplementary Figure
S1a; 11). These sites are essential for RA induction of tran-
scription (4,12,13), which depends on RAR, because un-
der the same conditions, RA is not able to induce CASP9
and CYP26A1 mRNAs in MCF10 cells, devoid of RA re-
ceptor (Supplementary Figure S1e and f) (14).
To monitor recruitment of the RA receptor to the pro-
moter and RARE elements after RA stimulation, we as-
sessed the timing of association of RA receptor with the
chromatin of CASP9 and CYP26A1 by ChIP. We included
in our analysis very early times after RA induction (min) to
detect the earliest chromatin changes induced by the hor-
mone. Figure 1c shows that RAR is rapidly (15 min) re-
cruited to theRARE element and to the upstreampromoter
of CASP9. We noticed that the levels of RAR recruited to
the promoter and RARE chromatin were not stable, but os-
cillated between 15 and 60 min after RA exposure. RAR
and RXR were also recruited to the RARE/promoter
of CYP26A1 (Supplementary Figure S1c and d). RAR
did not accumulate to the RARE or promoter of CASP9
gene in unresponsive MCF10 cells (Supplementary Fig-
ure S1f). Recruitment of RAR and RXR was associated
with accumulation of total and serine 5-phosphorylated
RNA polymerase II (Pol II and p-Pol II, respectively) at
the RARE and promoter regions of CASP9 and CYP26A1
(Figure 1d and e, and Supplementary Figure S1d). As ex-
pected, Pol II and p-Pol II accumulated preferentially at the
promoter relative to the RARE following RA induction.
Note that recruitment of total Pol II and p-Pol II to RARE
oscillated synchronously with the recruitment of RAR. p-
Pol II progressively accumulated at the CASP9 promoter
with the time of RA stimulation (Figure 1d and e, and Sup-
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Figure 1. Retinoic acid (RA) induction of CASP9mRNA and recruitment of retinoic acid receptor alpha (RAR) and phosphorylated RNA polymerase
II to retinoic responsive element (RARE) and promoter of CASP9 gene. (a) Structure of CASP9 gene. The TSS and the direction of transcription are
indicated by a green arrow; the exons, promoter, polyA addition sites and RARE are shown by different colors indicated at the upper right corner. The
black arrows indicate the primers used for ChIP and mRNA analysis. (b) Total RNA was prepared from MCF-7 hormone-starved or stimulated with
300-nM RA for 15, 30, 60 and 240 min and analyzed by qPCR with specific primers (panel (a)) to CASP9 mRNA normalized to 18S RNA levels. The
statistical analysis derived from at least three experiments in triplicate (n ≥9; mean ± SD); *P< 0.01 (matched pairs t-test) compared to RA-unstimulated
sample, **P < 0.01 (matched pairs t-test) comparing 30–60 min of RA exposure. (c, d, e) qChip analysis of RA-dependent occupancy of RAR, RNA
polymerase II (Pol II) and phosphorylated RNA polymerase II (p-Pol II) at the promoter and RARE. MCF7 cells were stimulated with 300-nM RA for
15, 30, 60 and 240 min. The chromatin was immunoprecipitated with antibodies directed against RAR, Pol II, p-Pol II. Panel (c) shows the recruitment
of RAR to the promoter and RARE sequences of CASP9 gene. Panels (d) and (e) show the recruitment of Pol II (d) and p-Pol II (e) at the promoter
and RARE. The black, horizontal line (brackets ± SD) in each plot indicates the percent of input from a control ChIP (Ab: non-immune serum). The
statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P< 0.01 (matched pairs t-test) compared to RA-unstimulated
sample; ◦◦P < 0.01 (matched pairs t-test) compared 15–30-min stimulated samples.
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plementary Figure S1d). The levels of p-Pol II at theCASP9
RARE dipped at 30 min and then increased over the next
240 min, preceding by 30 min the oscillations of the mRNA
levels (Figure 1b). The oscillation of RAR recruitment to
the CYP26 RARE promoter–RARE is delayed by 30 min
compared to that of CASP9 and mirrors the smaller and
higher peaks of mRNA accumulation at 30 and 240 min
following RA exposure (Supplementary Figure S1c and d).
mRNA levels of four other genes induced by RA display a
similar pattern with a small peak at 30–60 min and a large
peak at 240 min after RA (not shown). In CASP9 normal-
ization of p-Pol II with total Pol II shows that this ratio in-
creases dramatically 30 min after RA at the promoter, while
it is stable at the RARE (Figure 1d and e) mirroring the
rise and reduction of RNA at 30 and 60-min RA, respec-
tively (Figure 1b and Supplementary Figure S1b). However,
we note that at 30 min the change of the ratio is due to a
significant depletion of total PolII from the promoter (Fig-
ure 1d) which may explain the reduction of mRNA 30 min
later (Figure 1b). We believe that the loss of total Pol II at
the promoter 30 min after RA does not reflect an increased
Pol II phosphorylation, but instead, a change in chromatin
structure leading to depletion of Pol II with other proteins
bound to the promoter, including RAR (Figure 1c).
Histone H3K4 and H3K9 methylation marks induced by RA
Methylation of lysine 4 in histone H3 (H3K4) marks tran-
scribed loci, whereas dimethyl-lysine 9 in the same histone
(H3K9me2) is associated with transcription silencing (15).
To find the histone marks modified by RA exposure, we an-
alyzed the methylation profiles of H3K4 and H3K9 in cells
after treatment with RA. ChIP analysis was performed with
specific antibodies against methylated H3K4 and H3K9.
The regions analyzed were the promoter-TSS, the RARE
element and two polyA addition sites located at the 3′ end of
theCASP9. Two segments of the gene 2 kb distant from the
TSS were also included in the analysis. As a result of methy-
lation and demethylation events induced by RA, the levels
ofmethylatedK9orK4, normalized to the input chromatin,
were selectively modified shortly after RA exposure. Fig-
ure 2 shows that promoter-associated H3K4 me2 and me3
were transiently demethylated 15 min after RA challenge
and then progressively remethylated (Figure 2a and b).
Rapid demethylation of H3K4 at RAREwas also observed,
but remethylation was slower than at the promoter. RA
induced a transient loss of H3K9me2 and H3K9me3, fol-
lowed by accumulation of H3K9me2 but not of K3K9me3
(Figure 2c and d). The methylation changes observed were
not due to loss of H3 levels at these sites (Figure 2e and
f). These cyclical methylation–demethylation events were
strikingly synchronous and specific to the RARE and pro-
moter regions of CASP9. In contrast, H3 methylation was
unaffected by RA at a site 2 kb downstream of RARE
in intron II or in a non-RA-induced gene, TGFBI (Fig-
ure 2g). A similar methylation–demethylation cycle was ob-
served at the CYP26A1 promoter–RARE chromatin (Sup-
plementary Figure S2a and b). MCF10 cells, which do not
respond to RA (14; Supplementary Figure S1e and f), do
not show changes in methylation of H3K4, K9 me2/3 at
15-min RA (Supplementary Figure S2c). We also probed
the 3′ end of CASP9 gene, where two major polyA addi-
tion sites are located. H3K4me2 and me3 and H3K9me2 at
the polyA1 and polyA2 sites also underwent transient and
early demethylation. H3K9me3 was permanently demethy-
lated at the polyA2 site, but was essentially unchanged at
the polyA1 site (Supplementary Figure S2d–i). We con-
clude that the polyA1 and polyA2 sites undergo methy-
lation changes similar to those seen at the promoter and
RARE, raising the possibility that these regions are func-
tionally and physically associated in a unique chromatin do-
main.
To complete the description of chromatin factors di-
rectly or indirectly linked to the modification of histone
marks following RA induction of transcription, we mea-
sured the recruitment of a major histone methyltrans-
ferase (SUV39H1, which methylates H3K9) (16,17) (Sup-
plementary Figure S3a and b) or an alternative modifica-
tion of H3K9, such as H3K9 acetylated (H3K9Ac) (Sup-
plementary Figure S3c and d), or the recruitment of the
co-repressors, NCoR1 and NCoR2 (18,19) (Supplemen-
tary Figures S3e and f and S3g and h, respectively) to
the RARE–promoter and polyA addition sites of CASP9
and CYP26A1 genes. Supplementary Figure S3 shows that
the recruitment of these proteins to these sites following
RA induction mirrors the demethylation–methylation cy-
cles described above. SUV39H1 accumulates at the pro-
moter, RARE and polyA addition sites with a sharp peak
30 min following RA exposure (Supplementary Figure S3a
and b). The SUV39H1 recruitment overlaps with the peak
at 30min of bi- and tri-methylatedH3K9 in Figure 2c and d.
On the other hand, H3K9Ac oscillates symmetrically with
the demethylation wave of H3K9me2 and H3K9me3, sug-
gesting that H3K9 nucleosomes undergo mutually exclu-
sive demethylation–acetylation cycles (Supplementary Fig-
ure S3c and d). NCoR1 is transiently recruited at 15-min
RA, while NCoR2 is present in the absence of RA and pro-
gressively disappears from the RARE chromatin following
RA induction (Supplementary Figure S3e–h). Collectively,
these data describe a series of intertwined oscillating cyclic
events driven by RA and targeted to the RARE–polyA ad-
dition sites of CASP9 and CYP26A1 genes. The earliest
temporal event we are able to detect following RA expo-
sure is the massive demethylation of H3K4 and H3K9 in-
duced by RA at 15 min. This suggests that K4 and K9
demethylation enzymes are also recruited to CASP9 and
CYP26A1. H3K9me3 can be demethylated by enzymes of
the Jumonji C (JMJC) family (20,21), whereas H3K4me2
is demethylated in vitro (22) and H3K9me2 in vivo (7,23–
25) by LSD1 (KDM1). We decided to monitor the re-
cruitment at the RARE promoter chromatin of CASP9
and CYP26A1 of LSD1 and JMJD2A, which demethylate
H3K4me2 or H3K9me2 and H3K9me3, respectively. Fig-
ure 3a, b and Supplementary Figure S4a show recruitment
of both LSD1 and JMJD2A histone demethylases to the
RARE elements and promoters of CASP9 and CYP26A1
following RA treatment. Notably, the kinetics of recruit-
ment of LSD1 and JMJD2A parallels the kinetics of loss
of the H3K4me2 and H3K9me2/3. H3K9me2/3 accumu-
lation at 30-min RA is associated with the recruitment of
SUV39H1 (16) to the promoter, RARE and polyA addi-
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Figure 2. Methylation–demethylation cycles of histone H3K4/K9 induced by RA atCASP9 promoter–RARE chromatin. MCF7 cells were serum starved
and exposed to 300-nM RA at the indicated times (0, 15, 30, 60 and 240 min). qChIP was carried out using specific antibodies recognizing H3K4me3,
H3K4me2, H3K9me3 and H3K9me2. The specificity of the antibodies was tested by competition with the specific methylated peptide(s). (a, b) H3K4me2
and H3K4me3 occupancy at the CASP9 promoter and RARE. (c, d) H3K9me2 and H3K9me3 occupancy at the CASP9 promoter and RARE. The black
arrows indicate the loss of all methylated H3K4 and H3K9 (except H3K4me2 at the RARE) at 15-min RA. (e, f) ChIP Histone H3 at the promoter and
RARE after RA induction. (g) ChIP analysis of CASP9 II intron and of TGFBI exon 13 (non-RA-induced gene), in cells exposed to RA for 15, 30 and 60
min. For each antibody, the control IgG signal is shown (brackets ± SD). The statistical analysis was derives from at least three experiments in triplicate
(n ≥ 9; mean ± SD); *P < 0.01 (matched pairs t-test): compared to the RA-unstimulated sample; **P < 0.01 (student t-test): compared to the same time
point at the promoter and RARE.
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Figure 3. LSD1 and JMJD2A upon RA exposure are recruited to the CASP9 promoter and RARE sites and are essential for CASP9 induction by RA
and methylation–demethylation cycle. (a, b) Recruitment of LSD1 and JMJD2A to the promoter and RARE of CASP9 gene. MCF7 cells were serum
starved and exposed to 300-nMRA at the indicated times (15, 30, 60 and 240 min). qChIP was carried out using specific antibodies recognizing LSD1 and
JMJD2A. The panels show the time course of the recruitment of LSD1 (a) and JMJD2A (b) to the RARE and promoter sequences of CASP9 analyzed
by qPCR. The black, horizontal line in each plot indicates the percent of input from a control ChIP (Ab: non-immune serum). (c, d) LSD1 and JMJD2A
depletion inhibits RA-induced transcription ofCASP9. MCF7 were transiently transfected with LSD1 siRNA or JMJD2A siRNA. After 48 h, total RNA
was prepared from control cells (starved) or RA-induced cells (300-nMRA for 45min) and analyzed by qPCRwith specific primers toCASP9mRNA. The
statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P< 0.01 (matched pairs t-test) compared to RA-unstimulated
sample; **P< 0.01 (student t-test): comparison between SCR and specific siRNAs; ◦◦P< 0.01 (student t-test): comparison between promoter and RARE
regions. (e) Depletion of LSD1 or JMJ2DA inhibits the methylation changes induced by RA. qChIP was performed on cells transfected with LSD1
siRNA or JMJD2A siRNA and induced with 300-nM RA for 15 min. qChIP was carried out using specific antibodies recognizing H3K4me3, H3K4me2,
H3K9me3 and H3K9me2. The statistical analysis derives from at least three experiments in triplicate (n≥ 9; mean ± SD); *P< 0.01 (matched pairs t-test)
compared to RA-unstimulated sample; **P < 0.01 (student t-test): comparison between SCR and specific siRNAs. Transfection efficiency was monitored
by FACS (Alexa Fluor or co-transfected pEGFP Vector).
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tion sites (Supplementary Figure S3a and b). A new wave
of demethylation of H3K9me3 occurs at 60–260-min RA
as indicated by reduction of H3K9me3 and accumulation
of H3K9me2 (Figure 2c and d). The methylation changes
(H3K9me2/3) and the kinetics of LSD1 and JMJD2A re-
cruitment to CYP26A1 chromatin are very similar to those
seen at RARE (Figure 2b and Supplementary Figures S2b,
3a and b and S4a). We believe that this similarity is due to
the fact that the promoter and RARE are physically con-
tiguous in CYP26A1 but are separated in CASP9.
To demonstrate that both lysine demethylases were nec-
essary for RA-induced transcription, we knocked down
LSD1 and JMJD2A with specific siRNAs and induced the
cells with RA (Supplementary Figure S4b and c). Knock
down of either demethylase, as shown by retention of
di- and tri-methylated H3K4 and H3K9, significantly re-
duced RA-induced expression of CASP9 (Figure 3c and
d) and CYP26A1 (Supplementary Figure S4d and e). Re-
expression of the wild-type LSD1 or JMJD2A and not a
mutant formof these enzymes restoredRA-inducedCASP9
RNA levels (Figure 3c and d and data not shown) and re-
duced the levels of H3K4 and H3K9 both me2 and me3 as
in control cells (Figure 3e). These data were unexpected be-
cause LSD1 and JMJD2A do not demethylate H3K4me3,
although JMJD2A has been shown to bind H3K4me3 in
vitro (26,27).We suggest that JMJD2A targets toH3K4me3
another enzyme able to demethylate H3K4me3. Also, si-
lencing of either LSD1 or JMJD2A increases H3K4me3
levels, as a result of increased methylation of the me2 forms,
which accumulate when LSD1 is not functional.
To explore further the relationship between H3K9 and
H3K4 methylation and LSD1, we overexpressed an N-
terminal dominant-negative mutant (T110A) of LSD1
(LSD1ALA). Thismutant is still enzymatically active, but is
unable to target transcription factors (7,8). The LSD1ALA
mutant protein was defective in binding to the promoter
or RARE elements of CASP9 or CYP26A1 following RA
induction (Figure 4a and Supplementary Figure S5a, re-
spectively) and inhibited activation ofCASP9 orCYP26A1
transcription upon RA exposure (Figure 4b and Supple-
mentary Figure S5b). The methylation levels both H3K4
andH3K9me2were already low in the absence ofRA (basal
in Figure 4c–f) because LSD1ALAwas constitutively active
and not inducible by RA (Supplementary Figure S5c and
d). LSD1ALA was constitutively recruited to chromatin
because not only it inhibited RA induction of CASP9 or
CYP26A1 expression but also lowered the levels of methy-
lated H3K4me2 or H3K9me3 at promoters of non-RA-
induced genes (such as TGFBI; Figure 4g), which methyla-
tion status does not change upon RA induction. However,
the methylation–demethylation cycle at the RARE, pro-
moter and polyA addition sites (Figure 4 and Supplemen-
tary Figure S56) was abolished both inLSD1 and JMJD2A-
depleted cells (Figure 3e) and in LSD1ALA expressing cells
(Figure 4c–f) and was not dependent upon the basal methy-
lation levels of H3K4 and H3K9 (me2/3), which were high
in the former and low in the latter cells, respectively (Fig-
ures 3e and 4c–f).
Collectively, these data indicate that RA induces the
recruitment of both LSD1 and JMJD2A to the chro-
matin of CASP9 and CYP26A1 and demethylation of
H3K4me2 and H3K9 me2/me3 at the RARE, promoter
and polyA2 sites. These localized demethylation events by
both demethylases are essential for the induction of tran-
scription of CASP9 and CYP26A1 by RA (Figure 4b and
Supplementary Figure S5b).
Recruitment of base or nucleotide excision repair enzymes to
the RARE/promoter chromatin following RA induction
It was recently reported that nucleotide excision repair
(NER) enzymes are recruited to promoter and RARE el-
ements. NER is essential for the formation of discrete
chromatin loops and induction of transcription by RA
(28). Similarly, transcription-induced recruitment of base
excision repair (BER) enzymes (such as 8-oxoguanine-
glycosylase, OGG1) toMYC-Ebox DNA or to estrogen re-
sponsive elements has been described (25,29). Activation of
a Fe++ dioxygenase (JMJD2A) and a FAD oxidase (LSD1)
at the same chromatin sites (ERE or Ebox-promoters) trig-
gers local oxidation. Oxidized guanine (8-oxo-dG) is recog-
nized by OGG1 (8,25). That oxidation of guanine also oc-
curs after RA induction of transcription is shown in Supple-
mentary Figure S7a. We observed a rapid (15 min) nuclear
accumulation of 8-oxo-dG in discrete foci in MCF7 cells
exposed to RA. As predicted, production of 8-oxo-dG foci
was inhibited by LSD1 knockdown (Supplementary Figure
S7b). ChIP analysis showed that OGG1 was recruited to
the promoter andRARE elements ofCASP9 (Figure 5a) 15
min following RA treatment. At 30 min, occupancy at these
sites byOGG1markedly decreased. At 240min, OGG1was
detected at theRARE element but not at the promoter. Sim-
ilar oscillation ofOGG1 binding to theRARE/promoter of
CYP26A1 was also seen (Supplementary Figure S8a). RA
induces the binding of OGG1 to the ERE and promoter
sites with the same timing of nuclear 8-oxo-dG accumula-
tion (Supplementary Figure S7) indicating that 8-oxo-dG
accumulates at specific segments of RARE, promoter and
polyA addition sites. In fact, OGG1 recruitment was not
seen in non RA-induced genes or in segments distant (1–2
kb) from the TSSs ofCASP9 orCYP26A1 (Supplementary
Figure S8g).
Complexes enucleated by OGG1 seem important not
only for the repair of oxidized lesions but also for assembly
of transcription initiation complexes at estrogen- or Myc-
dependent promoters (8,25,30,31). To dissect the compo-
nents of the OGG1 complex that could link repair and RA-
induced transcription, we probed for other BER enzymes
that associate with a RARE element or its cognate pro-
moter after RA induction. Specifically, we monitored the
recruitment of: (i) the APurinic site Endonuclease1, APE1,
which recognizes the apurinic site generated by OGG1 and
cleaves the phosphodiester backbone, immediately 5′ to the
site; (ii) thymineDNAglycosylase (TDG), which is required
for BER of deaminated methylcytosine, a frequent prod-
uct of base oxidation; and (iii) uracil glycosylase (UNG),
which removes uracil or oxidized cytosine. Figure 5b, c and
d (Supplementary Figure S8a for CYP26A1) show that all
these enzymes are recruited to the promoter and to RARE
chromatin 15 min following RA induction similar to the re-
cruitment of RAR and Pol II (compare Figure 5 with Fig-
ure 1). We knocked down two of these enzymes (OGG1 and
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Figure 4. Expression of a dominant negative LSD1 mutant inhibits RA-induced methylation changes and CASP9 induction by RA. (a) Recruitment
of wild type (WT) and mutant LSD1 (LSD1ALA) to the CASP9 RARE–promoter. The LSD1ALA mutant contains a substitution of threonine with
alanine in position 110 and has been described elsewhere (17,19). MCF7 were transiently transfected with LSD1 vectors (WT or mutant), starved (Basal)
or treated with 300-nM RA for 30 min and were analyzed by qChIP using Anti-FLAG antibodies to recognize the recombinant LSD1. The panel shows
the recruitment of the flagged LSD1WT and LSD1ALA to the RARE and to the promoter sequences of CASP9. The black, horizontal line indicates the
percent of input from a control ChIP (Ab: non-immune serum). (b) LSD1ALA inhibits RA-induced CASP9 transcription. Total RNA was prepared from
MCF7 transiently transfected with LSD1WT or LSD1ALA. After 48 h, mRNAs from control cells (starved) or RA-induced cells (300-nMRA for 45 min)
were analyzed by qPCR with specific primers to CASP9 mRNA. (c, d) LSD1ALA inhibits RA-induced H3K4 demethylation. H3K4me2 and H3K4me3
occupancy at the promoter and RARE of CASP9 in LSD1ALA expressing cells as in (b). (e, f) LSD1ALA inhibits RA-induced H3K9 demethylation.
H3K9me2 and H3K9me3 occupancy at the promoter and RARE of CASP9 in LSD1ALA expressing cells as in (b). (g) ChIP analysis of TGFBI exon
13 (non-RA-induced gene), in transfected cells exposed to RA for 15, 30 and 60 min. For each antibody, the control IgG signal is shown (brackets ±
SD). The statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P < 0.01 (matched pairs t-test): compared to the
RA-unstimulated sample; **P < 0.01 (student t-test): comparison between control and the LSD1ALA expressing cells at the same time.
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Figure 5. Recruitment of BER and NER enzymes to CASP9 chromatin following RA induction. MCF7 cells, starved or treated with RA for 15, 30
and 240 min, were analyzed by qChIP using specific antibodies recognizing the 8-oxoguanine-DNA glycosylase-1 (OGG1), AP endonuclease (APE1),
Thymine-DNA glycosylase (TDG), Uracil-DNA glycosylase (UNG), XPG and RPA. (a, b) The recruitment of OGG1 and APE1 to the CASP9 promoter,
and RARE sequences. (c, d) The recruitment of TDG andUNG to the same regions ofCASP9. The black, horizontal line in each plot indicates the percent
of input from a control ChIP (Ab: non-immune serum). (e, f) BER knockdown impairs the expression of RA-induced CASP9. Serum-deprived MCF7
cells were treated for 45 min with 300-nMRA and specific siRNA targeting OGG1 or APE1; CASP9 expression levels were quantified by qPCR. To assess
the transfection efficiency cells were co-transfected with pEGFP Vector (Clontech) and analyzed by FACS. (g, h) The recruitment of XPG and RPA to
the CASP9 promoter and RARE. The statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P < 0.01 (matched
pairs t-test) compared to RA-unstimulated sample; **P < 0.01 (student t-test): comparison between SCR and specific siRNA; ◦◦P < 0.01 (student t-test):
comparison between the two amplicons.
 at U
niversita’ di N
apoli Federico II on M
arch 10, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
11050 Nucleic Acids Research, 2014, Vol. 42, No. 17
APE1; Supplementary Figure S8b and c) and asked if this
impacted onRA-induced transcription. Figure 5e and f and
Supplementary Figure S8d–f summarize the results of these
experiments. The activity of OGG1 and APE1 was essen-
tial for RA-induced transcription, since the wild type, but
not a OGG1 dominant negative or a catalytically defective
mutant APE1, reactivate CASP9 transcription induced by
RA in depleted cells (Figure 5e and f; Supplementary Fig-
ure S8d and e and data not shown).
Our results clearly indicate that depletion of these BER
enzymes significantly reduced RA-induced transcription.
We also probed for an NER enzyme (XPG) and for RPA,
a single strand binding protein (Replication Protein A) in-
volved in NER, on RARE by ChIP. XPG and RPA selec-
tively accumulated at RARE chromatin following 15min of
RA stimulation (Figure 5g and h and Supplementary Fig-
ure S8a). It has been reported recruitment of NER enzymes
to the RARE or other inducible promoters 3–4 h after hor-
monal induction, a period corresponding to maximal ac-
cumulation of specific mRNA levels (28). As expected, de-
pletion of XPG and RPA reduced RA-induced transcrip-
tion (not shown; 28). Our results show that BER and NER
accumulate early at the RARE and promoter, shortly be-
fore we could detect mRNA accumulation (Figure 1b and
Supplementary Figure S1b). The modifications we describe
mark the first transcription cycle of CASP9 and CYP26A1
induced by RA.
Formation of dynamic chromatin loops governing the selec-
tion of 5′ and 3′ borders of RA-induced transcription units
The data shown above indicate that the CASP9 and
CYP26A1 promoter, RARE and polyA addition sites un-
dergo similar changes in histone H3K4 and H3K9 methy-
lation and accumulate BER and NER enzymes after RA
treatment. This coordination is consistent with the idea that
these regions are physically associated after RA induction.
Note that the CASP9 RARE and 5′ start site are 9.5 kb
apart and the polyA site is 22 kb to the 3′ end ofRARE (Fig-
ure 1a). Recall that the methylation status H3K4 andH3K9
was not modified at chromatin neighboring these sites (2
kb at the 5′ and 3′ ends) and BER–NER enzymes were not
recruited to these sites in RA-treated cells (Figure 2e and
Supplementary Figure S8g).
These data suggest that RA induces early changes of spe-
cific chromatin domains that bring the TSS, the RARE and
the polyA addition sites into close proximity. To find the rel-
evant chromatin domains assembled in response to RA, we
systematically analyzed the structure ofCASP9 (Figure 6a)
and CYP26A1 (Supplementary Figure S9a) chromatin by
the 3C technique (see the Materials and Methods section).
Briefly, fixed chromatin DNAwas cleaved with a restriction
enzyme (NcoI) and ligated after dilution. Real-time qPCR
was then used to detect the ligated DNA segments. Fig-
ure 6a shows the summary of such analysis by using several
probes and ‘baits’ centered on the TSS, RARE and 3′ end
of CASP9 (see the legend of Figure 6 for the detailed band
analysis).
RA enhanced formation of two loops connecting the 5′
and 3′ ends of the gene with the RARE element. Exten-
sive quantitative analysis of these loops revealed: (i) a 5′ end
loop connecting the RARE to the promoter (A-F1, A-F2)
was induced by RA (Figure 6b); (ii) a loop (F1-L, F2-L)
connecting theRARE region to the 3′ end ofCASP9, where
two different polyA addition sites generate twomRNAends
(AB209147; AK303743). Assembly of this loop was almost
entirely dependent on RA treatment (Figure 6c); (iii) a loop
connecting the 5′ and the 3′ ends of the gene, bridging the
above-mentioned loops (A-L) (Figure 6d). We wish to note
that transcription of CASP9 is promoted by many different
stimuli. Thus, the loops formed in the absence of RA may
nevertheless reflect basal transcription.
Strikingly, formation of all of these loops is cyclical. They
first appear 15 min following RA exposure, disappear at 30
min and reform by 60 min. This oscillation resembles that
displayed in previous figures showing CASP9 mRNA syn-
thesis, promoter and RARE occupancy by protein factors
and histone modifications (Figures 1–5). The CYP26A1
gene also formed chromatin loops upon RA treatment.
Since RARE and promoter are contiguous in CYP26A1
we detected essentially one major loop connecting the 5′
(promoter-RARE) with the 3′ end of the gene (polyA ad-
dition sites). This loop peaked 15 min after RA and slowly
disappeared (Supplementary Figure S9b and c) similar to
the early loop induced by RA on CASP9 chromatin (Fig-
ure 6e). The physical association of the 5′ and 3′ ends of
CASP9 and CYP26A1 genes induced by RA implies that
the same proteins are present at the chromatin of the pro-
moter, RARE and 3′ end sites. The physical contiguity (600
bp) of the two polyA addition sites (1 and 2) does not dis-
criminate which polyA1 or 2 is included in the RA-induced
loop of CASP9 gene.
To find a 3′-end-specific RA-dependent marker of
CASP9, we investigated the localization on CASP9 chro-
matin of Ssu72, a protein which marks the 3′ end of genes
and interacts with the general transcription initiation factor,
TFIIB (32). Supplementary Figure S10a, b and c shows that
Ssu72 binds the promoter and RARE with the same kinet-
ics seen with RAR and Pol II following RA exposure, i.e. a
peak at 15 min corresponding to the early RA-induced loop
(Figure 6e). At 15 min after RA, Ssu72 disappeared from
the polyA2 and concentrated at the promoter and RARE
(Supplementary Figure S10a and b). Apparently, Ssu72 was
present at the polyA2 site of CASP9 gene in the absence
of RA induction, except at 15′ min after RA, when the re-
ceptor and the promoter were recruiting Pol II and RAR
(Supplementary Figure S10a–c).
How relevant are these loops to RA-induced transcrip-
tion and how they are linked to the demethylation cycles
induced by RA? To address this question we measured the
loops involving RARE in cells expressing the LSD1ALA
mutant. Expression of LSD1ALA inhibited RA-induced
demethylation (Figure 4c–f and Supplementary Figure S6)
and RA-induced transcription (Figure 4b). Supplementary
Figure S10d shows that the formation of the 15-min loops
connecting RARE to the polyA1/2 site or to the promoter
upon RA exposure was inhibited: some loops were delayed
(RARE-polyA1/2) and some others were completely elim-
inated (RARE–promoter).
We conclude that the demethylation cycles triggered by
RA govern the ordered formation of the loops essential for
RA-induced transcription.
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Figure 6. Formation of dynamic chromatin loops during early RA-induced transcription. 3C analysis of CASP9 chromatin in MCF7 cells exposed to 300
nM of RA for various periods of time. (a) The histograms show the frequency of ligation of the CASP9 NcoI fragments amplified with primers indicated
below the NcoI restriction map. All the combinations of primers indicated were performed on ligated chromatin; the histogram shows qPCR amplifications
above 1%, relative to the control. Each loop was detected with different primers pairs and the two histograms show the analysis by using several probes
and ‘baits’ centered at the TSS, RARE and 3′ end of the CASP9. Differences between recombinant, Basal and RA-treated cells derived-chromatin were
tested for statistical significance using Student’s t-test: *P < 0.01 as compared to untreated control. (b, c, d) Time course of chromatin looping following
RA induction. 3C analysis was carried out as described in the Materials and Methods section and the loops shown in panels (b, c, d) were quantified by
qPCR (left panels) and verified by gel electrophoresis (right panels) and DNA sequencing (data not shown). The results shown derive from at least three
experiments in triplicate (n ≥ 9; mean ± SD). *P < 0.01 as compared to untreated samples. (e) The panel shows the time course of loop formation. Data
were collected from real-time qPCR and from semi-quantitative, nested PCR, experiments. The extra band seen in panel (c) is a skipped restriction site
that adds 187 bp to the expected fragment (210 bp). This band is specific because the same loop (RARE-polyA) analyzed with another primer (F1) does
not produce extra bands. Also, following the treatment with RA, this longer fragment accumulates while the shorter one (cleaved by the enzyme in the
chromatin) almost disappears. This indicates that this site is protected in vivo and is not cleaved efficiently by NcoI restriction enzyme.
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DISCUSSION
The data reported here show that the methylation changes
of K4 and K9 of histone H3 are linked to the recruitment
of repair enzymes and, most importantly, to the formation
of chromatin-DNA loops that juxtapose the 5′ end TSS,
the enhancer (RARE) and the 3′ end of the transcribed
gene (Figure 6 and Supplementary Figures S9 and S10).
Histone methylation–demethylation cycles (33) and the for-
mation of loops connecting the 5′ gene ends, 3′ ends and
enhancers have been described extensively in many genes
induced by nuclear receptors (28,33). However, these as-
pects of chromatin movement, although required for tran-
scription induction by nuclear hormones, have not been
mechanistically and temporally linked. Likewise, the asso-
ciation of methylation–demethylation cycles with NER en-
zyme recruitment to RA-induced promoter(s) and the for-
mation of loops upon exposure to RA has not been de-
scribed, although depletion of these enzymes seriously com-
promises transcription and chromatin looping induced by
RA (28). However, notwithstanding the plethora of data,
the mechanism used by RA or other inducers to trigger
the recruitment of NER enzymes and formation of chro-
matin loops is still not known. Our experiments show that
demethylation–methylation cycles of H3K4 and K9 at the
RARE, promoter (Figure 2) and 3′ gene end (Supplemen-
tary Figure S2d–g) are the initiating and earliest events in-
duced by the recruitment of the RA–RAR complex to the
RARE. The timing and the kinetics of demethylation of
H3K4 and K9 are similar at the promoter, RARE (Fig-
ure 6d) and the 3′ end of the gene, suggesting that these
sites, although not contiguous in the DNA, are included
in the same complex, driven by active RA–RAR. Inhi-
bition of demethylation of H3K4 and H3K9 by depleting
the demethylating enzymes (LSD1 or JMJD2A) or by ex-
pressing a dominant negative LSD1 variant (7,8) inhibits
RA-induced transcription (Figure 3c and d and Supplemen-
tary Figure S4d and e), nuclear dG oxidation (Supplemen-
tary Figure S7b), recruitment of BER (25) and NER en-
zymes and formation of loops induced by RA (Supplemen-
tary Figure S10d). Formation of the chromatin loops with
discrete 5′ and 3′ borders is facilitated by local DNA ox-
idation following demethylation by LSD1, which presum-
ably releases supercoiling and rigidity of the helix and tar-
gets BER andNER enzymes to oxidized bases (34; Antonio
Pezone & Antonio Porcellini, manuscript in preparation).
In all cases, BER and NER enzymes are essential to local-
ize and repair DNA nicks and altered bases produced by
dG and 5mdC oxidation (25,31,35). We wish to stress that
inhibition of H3K4-K9 methylation–demethylation cycles
or depletion of BER or NER enzymes or overexpression
of LSD1ALA does not influence the expression or modify
the chromatin of RA-independent genes (Figures 2g and 4g
and Supplementary Figures S4f and g and S8f). Locally,
LSD1-triggered demethylation produces hydrogen perox-
ide, which oxidizes dG (Supplementary Figure S7) and both
H3K9me2 and H3K4me2, as LSD1 substrates (7,8,25) may
favor dG oxidation. We do not know if H3K9m2/3 coexist
with H3K4me2/3 nucleosomes, but our data show a rapid
demethylation 15 min after RA, involving both H3K4 and
H3K9 N-terminals at the RARE–promoter and polyA ad-
dition sites (Figure 2 and Supplementary Figure S2d–g).
At these sites, 4 h after RA, the content of H3K9me3 and
H3K4me3 is low and high, respectively, as expected in tran-
scriptionally active genes (36). The presence of H3K4me2/3
and H3K9me2/3 at time 0 at the promoter or RARE may
indicate that these sites are poised between repression and
activation depending on the strength of the specific stimu-
lus. Also, RARE nucleosomes containing H3K9me2 may
express less CASP9 and this may contribute to the setting
of discrete expression states in cell populations.
Further complicating comparative analysis of the data
published thus far are the different temporal frames used
in various studies to describe the molecular events induced
by transcriptional activators. These studies have been car-
ried out at 1 h (37) to several hours or days (28) after hor-
monal induction. At these times, synchronization is lost.
Each cell is starting and restarting the transcription cycle
and only the mature RNA accumulates exponentially and
can be easily detected even in asynchronous transcribing
cell populations. The H3 (K4-K9) methylation code, hours
and days after the initial RA induction, is not informative
sinceH3K4me2/3 andH3K9me2/3 content is high and low
both in control and chronically stimulated cells, respectively
(33).
An important feature of RA-induced transcription re-
ported here is the timing and synchronous oscillation with
a period of ca. 30 min of chromatin bound RAR, Pol II,
H3K4-H3K9 demethylation, H3K9Ac and looping involv-
ing the RARE and the 5′ and 3′ of CASP9 and CYP26A1
genes (Figure 6). RA-induced mRNA levels of CASP9,
CYP26A1 and five other genes (A. Pezone, unpublished ob-
servations) oscillate with a period of 60 min from the ini-
tial induction with RA. With the time (2–4 h) this periodic
oscillation is lost (Figure 6). We do not know if this loss
of synchrony with the time is due to our inability to track
these chromatin changes in non-synchronized cell popula-
tions or whether the oscillation we observe is limited to
the first transcription cycle. An early and similar cycle of
transcription induced by estrogens has been reported to be
unproductive in terms of RNA accumulation. This cycle
is suggested to prepare the promoter for subsequent tran-
scription followed by two different transcriptionally pro-
ductive cycles (38–40). However, our data suggest that (i)
the first cycle (unproductive in 38–40) is indeed the cycle
(15–30 min) that sets and defines the physical borders of the
transcription unit induced by the hormone (in our case RA)
and (ii) the oscillations in RAR recruitment (Figure 1) and
chromatin looping (Figure 6) are driven by methylation–
demethylation cycles of histone H3K4 and H3K9, caused
by alternate recruitment of demethylating (LSD1-JMJD2A
in Figure 3a and b and Supplementary Figure S4a) and
methylating (Supplementary Figure S3a and b) enzymes.
We believe that these oscillations are important for BER
and NER enzymes to repair oxidized DNA (Figure 5 and
Supplementary Figure S8a) to restart the cycle.
We wish to note that although the structural orga-
nization of the RARE is different comparing CASP9
(RARE 4 kb downstream the promoter) with CYP26A1
(RARE contiguous with the promoter) genes, the timing of
methylation–demethylation, the oscillation of RAR and
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LSD1-JMJD2A recruitment to the RARE promoter ap-
pear very similar
Why should the definition of the physical borders of a
transcription unit be important? Each gene in eukaryotes
is indeed the target of many stimuli, which can indepen-
dently induce transcription. The protein Ssu72 has been
identified in yeast as an element required for marking the 3′
end of the chromatin loops and transcription directionality
(41,42). The human protein Ssu72, although has not been
shown to be involved in DNA-chromatin loops, may have
a similar function in human cells as suggested by the crys-
tal structure of the complex of RNA polymerase C termi-
nal domain, a scaffold protein symplekin, and human Ssu72
(43).
The accumulation of Ssu72 in the various sites ofCASP9
gene, before and after RA induction, may indicate the
changes of chromatin engaged in RA-induced and RA-
independent transcription. This protein is present at 3′ end
ofCASP9 3′ end before RA induction, disappears from this
site at 15 min and reappears 30 min after RA treatment
(Supplementary Figure S10a–c). Fifteen minutes after RA
stimulation, Ssu72 moves from the 3′ end to the CASP9
TSS and RARE (Supplementary Figure S10a–c), where its
concentration oscillates synchronously with methylation–
demethylation cycles and recruitment of BER andNER en-
zymes (Figures 2 and 5 and Supplementary Figure S10).
These data indicate that Ssu72 specifies the 3′ end of both
RA-dependent and -independent transcription units (Sup-
plementary Figure S10c), which are also marked by end-
and time-selective-specific chromatin loops. Importantly,
after RA induction, RA-independent transcription is shut
off to allow the formation of RA-dependent loops. This is
shown by the shift of Ssu72 from the polyA2 addition site
(in the absence of RA) to the RARE (15 min after RA)
(Supplementary Figure S10a–c) and by the time synchrony
of the loops induced by RA (Figure 6e). LSD1 is essential
for this event, because the synchrony of loop formation is
lost in cells expressing the LSD1ALA mutant: some loops
disappear (promoter-RARE) or are delayed (promoter-
polyA or RARE-polyA) and resemble loops formed in the
absence of RA (Supplementary Figure S10d). It is worth
noting that LSD1 has been recently shown to control the
rhythmicity and the circadian clock and that amutant in the
residue adjacent (aa 111) to that of LSD1ALA (aa 110) is
unable to reset clock oscillations (44). We suggest that RA-
induced synchronous demethylation–methylation cycles in-
hibit ongoing local transcription and trigger recruitment of
BER and NER enzymes to the chromatin of CASP9 pro-
moter, RARE and 3′ end. The simultaneous DNA and his-
tone changes bring in close proximity the 5′, enhancer and
3′ ends of CASP9 and induce the formation of loops (Fig-
ure 6 and Supplementary Figure S10). Figure 7 shows a
summary of temporal changes induced by RA on the target
chromatin, including histone H3K9 acetylation, methyla-
tion, demethylation, recruitment of co-repressors NCoR1-
2, of BER andNER enzymes and the formation of the loop
connecting RARE and promoter in CASP9 gene. We pro-
pose that these cycles are intertwined and triggered by his-
tone methylation–demethylation cycles.
We believe that RA-induced synchronization of DNA
chromatin loops is required for calibration and rapid rein-
Figure 7. RA-induced cycles of histone H3K9 methylation, acetylation,
recruitment of NCoR1–2, BER, NER and RARE–promoter chromatin
loop. Time course of the major modifications of histone H3K9 at the
RARE ofCASP9 andCYP26A1 genes. The original data are in Figures 2,
5 and 6 and Supplementary Figures S2, S3, S8, S9 and S10. On the ordinate
are indicated: i. fold-induction (arbitrary units); ii. the type of assay (ChIP
or 3C). The time of RA induction is shown on the abscissa. The bottom
panel shows the frequency of loop formation between RARE–promoter of
CASP9 gene in cells expressing wild type or LSD1ALA (Supplementary
Figure S10d).
duction of transcription rather than for high levels of tran-
scription. The massive accumulation of RA-specific mR-
NAs, in fact, occurs hours after the initial RA exposure (45).
This efficient reinduction of transcription may represent a
‘transcription memory’, which has been noted before and
requires gene looping and Ssu72 in yeast (46,47).
The periodic variation of recruited receptor at the en-
hancer represents a simple mechanism to titrate and cali-
brate the concentration of RA molecules present in the en-
vironment. Any drop in the inducer levels reduces the con-
centration of active receptor at the enhancer leading to dis-
solution of the chromatin DNA loop enucleated initially by
the active receptor (RARE–promoter). Conversely, a rise in
levels of the inducer rapidly reactivates transcription by sta-
bilizing the loops (transcription memory) (see the Supple-
mentary Movie).
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